Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice
venous thromboembolismcancerlow-molecular-weight heparinvitamin K antagonistrecurrent thrombosis
